Functioning and interpersonal relationships as predictors of response in treatment-resistant depression

Comprehensive Psychiatry

Volumn 44, Issue 1, 2003, Pages 44-50

  Papakostas, George I ^a   Petersen, Timothy ^a   Mischoulon, David ^a   Hughes, Megan E ^a   Spector, Andrew R ^a   Alpert, Jonathan E ^a   Fava, Maurizio ^a   Nierenberg, Andrew A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; LITHIUM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; ELECTROCONVULSIVE THERAPY; EMPLOYMENT; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; JOB PERFORMANCE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HEALTH; OPEN STUDY; OUTCOMES RESEARCH; PREDICTION; RATING SCALE; SCORING SYSTEM; SOCIAL INTERACTION; STATISTICAL SIGNIFICANCE;

EID: 0037217431     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1053/comp.2003.50012     Document Type: Article

References (36)

1. Joyce PR, Paykel ES. Predictors of drug response in depression. Arch Gen Psychiatry 1989;46:89-99.
2. Downing RW, Rickels K. Predictors of amitriptyline response in outpatient depressives. J Nerv Ment Dis 1972;154: 248-263.
3. Roundaville BJ, Weissman MM, Prusoff BA, Herceg-Baron RL. Marital disputes and treatment outcome in depressed women. Compr Psychiatry 1979;20:483-490.
4. George LK, Blazer DG, Hughes DC, Fowler N. Social support and the outcome of major depression. Br J Psychiatry 1989;154:478-485.
5. Vallejo J, Gasto C, Catalan R, Bulbena A, Menchon JM. Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators. J Affect Disord 1991;21:151-162.
6. Keitner GI, Ryan CE, Miller IW, Normand WH. Recovery and major depression: factors associated with twelve-month outcome. Am J Psychiatry 1992;149:93-99.
7. Koivumaa-Honkanen H, Honkanen R, Antikainen R, Hintikka J, Laukkanen E, Honkalampi K, et al. Self-reported life satisfaction and recovery from depression in a 1-year prospective study. Acta Psychiatr Scand 2001;103:38-44.
8. Akiskal HS. Factors associated with incomplete recovery in primary depressive illness. J Clin Psychiatry 1982;43:266-271.
9. Kocsis J, Mason BJ, Frances AJ, Sweeney J, Mann JJ, Marin D. Predictors of response of chronic depression to imipramine. J Affect Disord 1989;17:255-260.
10. Hoencamp E, Haffmans PMJ, Duivenvoorden H, Knegtering H, Dijken WA. Predictors of (non-) response in depressed outpatients treated with a three-phase sequential medication strategy. J Affect Disord 1994;31:235-246.
11. Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, et al. Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry 1998;59:669-75.
12. Beck AT, Steer RA. Manual for the Revised Beck Depression Inventory. San Antonio, TX: Psychological Corp, 1987.
13. Kaplan RM, Anderson JP. The general health policy model: an integrated approach. In: Spilker B (ed). Quality of Life and Pharmacoeconomics in Clinical Trials. Ed. 2. Philadelphia, PA: Lippincott-Raven, 1996:309-321.
14. Pyne JM, Bullock D, Kaplan RM, Smith TL, Gillin C, Golshan S, et al. Health-related quality of life measures enhances acute treatment response prediction in depressed inpatients. J Clin Psychiatry 2001;62:261-268.
15. Moos RH. Depressed outpatients' life contexts, amount of treatment, and treatment outcome. J Nerv Ment Dis 1990; 178:105-112.
16. Gloag D. Occupational rehabilitation and return to work 2 - psychiatric disability. Br Med J 1985;290:1201-1203.
17. Perl J, Kahn M. The effects of compensation on psychiatric disability. Soc Sci Med 1983;17:439-443.
18. Covi L, Lipman RS, Alarcon R, Smith VK. Drug and psychotherapy interactions in depression. Am J Psychiatry 1976;133:502-508.
19. Scott J, Barker WA, Eccleston D. The Newcastle chronic depression study. Patient characteristics and factors associated with chronicity. Br J Psychiatry 1988;152:28-33.
20. Riise T, Lund A. Prognostic factors in major depression: a long-term follow-up study of 323 patients. J Affect Disord 2001:297-306.
21. Melville DI, Hope D, Bennison D, Barraclough B. Depression among men made involuntarily redundant. Psychol Med 1985;15:789-793.
22. Rodriguez E, Frongillo EA, Chandra P. Do social programmes contribute to mental well-being? The long-term impact of unemployment on depression in the United States. Int J Epidemiol 2001;30:163-170.
23. Kendler K, Thornton L, Prescott C. Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am J Psychiatry 2001;158:587-593.
24. Gunnell D, Shepherd M, Evans M. Are recent increases in deliberate self-harm associated with changes in socioeconomic conditions? An ecological analysis of patterns of deliberate self-harm in Bristol 1972-3 and 1995-6. Psychol Med 2000;30:1197-1203.
25. Hawton K, Harriss L, Hodder K, Simkin S, Gunnell D. The influence of the economic and social environment on deliberate self-harm and suicide: an ecological and person-based study. Psychol Med 2001;31:827-836.
26. Kposowa AJ. Unemployment and suicide: a cohort analysis of social factors predicting suicide in the US National Longitudinal Mortality Study. Psychol Med. 2001;31:27-138.
27. Maciejewski PK, Prigerson HG, Mazure CM. Self-efficacy as a mediator between stressful life events and depressive symptoms: differences based on history of prior depression. Br J Psychiatry 2000;176:373-378.
28. Swindle RW, Cronkite RC, Moos RH. Life stressors, social resources, coping, and the 4-year course of unipolar depression. J Abnormal Psychol 1989;98:468-477.
29. First MB, Spitzer, RL, Gibbon M, Williams, BW. The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II): I. Description. J Personal Disord 1995;9:83-91.
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
31. Keller MB: The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987;44:540-548.
32. Keller MB, Lavori PW, McDonald-Scott P, Endicott J, Andreason N, Van Eerdewegh MM. The reliability of retrospective treatment reports. Psychiatry Res 1983;9:81-88.
33. Scott J, Eccleston D, Boys R. Can we predict the persistence of depression? Br J Psychiatry 1992;161:633-637.
34. Aberg-Wistedt A, Agren H, Ekselius L, Bengtson F, Akerblad AC. Sertraline versus paroxetine in major depression: clinical outcome after six months of continuous therapy. J Clin Psychopharmacol 2000;20:645-652.
35. Freud S: Civilization and its discontents. In: Strachey J, Gay P (eds). Paperback Reissue edition. New York, NY: Norton, 1989:30.
36. Rush AJ, George MS, Sackeim HA, McCangell LB, Husain NM, Giller C, et al. Vagus nerve stimulation (VNS) for treatment-resistent depressions: a multicenter study. Biol Psychiatry 2000;47:276-286.